Prevalence of use and acute toxicity associated with the use of NBOMe drugs
- PMID: 25658166
- DOI: 10.3109/15563650.2015.1004179
Prevalence of use and acute toxicity associated with the use of NBOMe drugs
Abstract
Introduction: The 25X-NBOMe series are N-2-methoxybenzyl analogues of the respective 2C-X substituted phenethylamine and include 25B-N(BOMe)2, 25B-NBOMe, 25C-NBOMe, 25D-NBOMe, 25E-NBOMe, 25G-NBOMe, 25H-NBOMe, 25I-NBOMe, 25N-NBOMe and 25iP-NBOMe. There are reports of their use as novel psychoactive substances and associated acute toxicity from Europe, the United States and elsewhere over the last five years. This review will discuss the epidemiology of use and pattern of acute toxicity associated with use of these compounds.
Methods: A PubMed search was performed using the search terms 'NBOMe', '25B-N(BOMe)2', '25B-NBOMe', '25C-NBOMe', '25D-NBOMe', '25E-NBOMe', '25G-NBOMe', '25H-NBOMe', '25I-NBOMe', '25N-NBOMe' and '25iP-NBOMe' covering the years 1966-2014. In addition, abstracts from the 2010-2014 congresses of the European Association of Poisons Centres and Clinical Toxicologists and the 2010-2013 North American Congress of Clinical Toxicology were reviewed using these search terms. Further information was obtained from the European Information System and Database on New Drugs co-ordinated by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). PREVALENCE OF USE: There are no national or international surveys collecting data on the prevalence of use of NBOMe drugs. The only information on prevalence of use is from two sub-population surveys of individuals who frequent nightclubs. Of 22,289 respondents of the 2013 Global Drugs Survey, 582 (2.6%) had previously used an NBOMe; the most commonly used NBOMe was 25I-NBOMe (442 respondents, 2.0% of whole cohort and 75.9% of those who had used an NBOMe). In a survey of 397 clubbers in London nightclubs in 2013, 11.8% had heard of the NBOMe drugs (compared with 96.0% for mephedrone), and 4.8% had ever used an NBOMe (compared with 76.6% for mephedrone). ACUTE TOXICITY: There were 29 published cases in the literature of acute toxicity associated with the use of an NBOMe: 25I-NBOMe - 23 cases; 25B-NBOMe - 3 cases; 25C-NBOMe - 3 cases. Commonly reported features include tachycardia (96.6%), hypertension (62.0%), agitation/aggression (48.2%), seizures (37.9%) and hyperthermia (27.6%). Five patients were reported to have developed acute kidney injury. There were an additional 25 reports of acute toxicity related to the use of 25I-NBOMe reported to the EMCDDA. The pattern of toxicity in these cases is similar to that seen in the published cases. NBOMe-related deaths. 25I-NBOMe has been detected in eight fatalities; in one of these, 25C-NBOMe was also detected. The role of the NBOMe drugs in these deaths has not been determined in all cases.
Conclusions: Currently, there is evidence suggesting limited use of the NBOMe class of drugs as novel psychoactive substances compared with that of classical recreational drugs and other novel psychoactive substances such as mephedrone.
Keywords: Acute toxicity; NBOMe; Novel psychoactive substances; Recreational drugs.
Similar articles
-
Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe.Clin Toxicol (Phila). 2014 Jun;52(5):561-5. doi: 10.3109/15563650.2014.909932. Epub 2014 Apr 29. Clin Toxicol (Phila). 2014. PMID: 24779864
-
Case series: toxicity from 25B-NBOMe--a cluster of N-bomb cases.Clin Toxicol (Phila). 2016;54(2):141-6. doi: 10.3109/15563650.2015.1115056. Epub 2015 Dec 1. Clin Toxicol (Phila). 2016. PMID: 26621342
-
NBOMe designer drug exposures reported to Texas poison centers.J Addict Dis. 2014;33(3):196-201. doi: 10.1080/10550887.2014.950027. J Addict Dis. 2014. PMID: 25115175
-
2C-I-NBOMe, an "N-bomb" that kills with "Smiles". Toxicological and legislative aspects.Drug Chem Toxicol. 2015 Jan;38(1):113-9. doi: 10.3109/01480545.2014.911882. Epub 2014 May 1. Drug Chem Toxicol. 2015. PMID: 24785196 Review.
-
Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP).Clin Toxicol (Phila). 2012 Sep;50(8):727-32. doi: 10.3109/15563650.2012.716158. Epub 2012 Aug 10. Clin Toxicol (Phila). 2012. PMID: 22882169 Review.
Cited by
-
The novel psychoactive substance 25E-NBOMe induces reward-related behaviors via dopamine D1 receptor signaling in male rodents.Arch Pharm Res. 2024 Apr;47(4):360-376. doi: 10.1007/s12272-024-01491-4. Epub 2024 Mar 29. Arch Pharm Res. 2024. PMID: 38551761
-
Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential.Nat Commun. 2023 Dec 15;14(1):8221. doi: 10.1038/s41467-023-44016-1. Nat Commun. 2023. PMID: 38102107 Free PMC article.
-
Neurotoxic effects of hallucinogenic drugs 25H-NBOMe and 25H-NBOH in organotypic hippocampal cultures.Heliyon. 2023 Jun 28;9(7):e17720. doi: 10.1016/j.heliyon.2023.e17720. eCollection 2023 Jul. Heliyon. 2023. PMID: 37449113 Free PMC article.
-
Rewarding and Reinforcing Effects of 25H-NBOMe in Rodents.Brain Sci. 2022 Nov 2;12(11):1490. doi: 10.3390/brainsci12111490. Brain Sci. 2022. PMID: 36358416 Free PMC article.
-
Effect of -NBOMe Compounds on Sensorimotor, Motor, and Prepulse Inhibition Responses in Mice in Comparison With the 2C Analogs and Lysergic Acid Diethylamide: From Preclinical Evidence to Forensic Implication in Driving Under the Influence of Drugs.Front Psychiatry. 2022 Apr 21;13:875722. doi: 10.3389/fpsyt.2022.875722. eCollection 2022. Front Psychiatry. 2022. PMID: 35530025 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials